Dioscorea bulbifera L.-induced hepatotoxicity and involvement of metabolic activation of furanoterpenoids

References

• Byrns MC, Predecki DP, Peterson LA. 2002. Characterization of nucleoside adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem Res Toxicol. 15(3):373–379.
   PubMed Web of Science ®Google Scholar
• Byrns MC, Vu CC, Peterson LA. 2004. The formation of substituted 1,N6-etheno-2′-deoxyadenosine and 1,N2-etheno-2′-deoxyguanosine adducts by cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem Res Toxicol. 17(12):1607–1613.
   PubMed Web of Science ®Google Scholar
• Chen XW, Serag ES, Sneed KB, Zhou SF. 2011. Herbal bioactivation, molecular targets and the toxicity relevance. Chem Biol Interact. 192(3):161–176.
   PubMed Web of Science ®Google Scholar
• Cheng F. 1995. 8 case reports of toxic hepatitis induced by Dioscorea bulbifera. Jangsu J Tradit Chin Med. 16(7):9.
   Google Scholar
• Chinese Pharmacopoeia Commission. 2015. Pharmacopoeia of the People’s Republic of China. Beijing (China): Chemical Industry Press.
   Google Scholar
• Demetzos C, Dimas K, Hatziantoniou S, Anastasaki T, Angelopoulou D. 2001. Cytotoxic and anti-inflammatory activity of labdane and cis-clerodane type diterpenes. Planta Med. 67(7):614–618.
   PubMed Web of Science ®Google Scholar
• Feng JH. 1989. 2 case reports of toxic hepatitis induced by Dioscorea bulbifera. Shandong J Tradit Chin Med. 8(2):30.
   Google Scholar
• Gao Y. 2006. Liver damage associated with combination of Sanjin tablets and Longbishu capsules. Adv Drug Reactions J. 8(4):305.
   Google Scholar
• Gao HY, Hou BL, Kuroyanagi M, Wu LJ. 2007. Constituents from anti-tumor-promoting active part of Dioscorea bulbifera L. in JB6 mouse epidermal cells. Asian J Tradit Med. 2(3):104–109.
   Google Scholar
• Gingipalli L, Dedon PC. 2001. Reaction of cis- and trans-2-Butene-1,4-dial with 2′-deoxycytidine to form stable oxadiazabicyclooctaimine adducts. J Am Chem Soc. 123(11):2664–2665.
   PubMed Web of Science ®Google Scholar
• Grynberg NF, Echevarria A, Lima JE, Pamplona SS, Pinto AC, Maciel MA. 1999. Anti-tumour activity of two 19-nor-clerodane diterpenes, trans-dehydrocrotonin and trans-crotonin, from Croton cajucara. Planta Med. 65(8):687–689.
   PubMed Web of Science ®Google Scholar
• Guan XR, Zhu L, Xiao ZG, Zhang YL, Chen HB, Yi T. 2017. Bioactivity, toxicity and detoxification assessment of Dioscorea bulbifera L.: a comprehensive review. Phytochem Rev. 16(3):573–601.
   Web of Science ®Google Scholar
• Guengerich FP. 2003. Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions. Arch Biochem Biophys. 409(1):59–71.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. 2008. Cytochrome P450 and chemical toxicology. Chem Res Toxicol. 21(1):70–83.
   PubMed Web of Science ®Google Scholar
• Hu Z, Zhou S, Zhang N, Li W, Lin D, Peng Y, Zheng J. 2018. Development of polyclonal antibodies for detection of diosbulbin B-derived cis-enedial protein adducts. Chem Res Toxicol. 31(4):231–237.
   PubMed Web of Science ®Google Scholar
• Huang ZF, Hua BC, Chen XF, Shi DH, Cheng XL, Wang YH, Liao HJ. 2013. Analysis of liver injury in 78 cases caused by Rhizoma Dioscoreae bulbiferae and related preparation. Chin J Exp Med Formul. 19(23):295–297.
   Google Scholar
• Ji H, Song N, Ren J, Li W, Zhang L, Xu B, Li H, Shen G, Li H. 2020. Systems toxicology approaches reveal the mechanisms of hepatotoxicity induced by diosbulbin B in male mice. Chem Res Toxicol. 33(6):1389–1402.
   PubMed Web of Science ®Google Scholar
• Jiang DS. 1976. 4 case reports of toxic hepatitis induced by Dioscorea bulbifera (Abstract). New Med. 7(01):30.
   Google Scholar
• Jiang S. 1978. Dictionary of Chinese Crude Drugs. Shanghai (China): Shanghai Scientific Technological Publisher.
   Google Scholar
• Jiang H, Cai B, Zhao W. 2011. A case of severe liver damage induced by Longbishu capsules. People Mil Surg. 54(10):893.
   Google Scholar
• Jiang JZ, Yang BH, Ji LL, Yang L, Mao YC, Hu ZH, Wang ZT, Wang CH. 2017. Metabolic-induced cytotoxicity of diosbulbin B in CYP3A4-expressing cells. Toxicol in Vitro. 38:59–66.
   PubMed Web of Science ®Google Scholar
• Jiang M, Xiong NN, Liu SL, Fu WM, Ye B, Chen J. 2004. Adverse drug reaction of compound prescription of Huangyaozi (Dioscorea Bulbifera L.) in clinical trial and its management. Chin J Evid-Based Med. 04(4):255–257.
   Google Scholar
• Jiang ZF. 1981. 17 case reports of drug-induced liver disease induced by Dioscorea bulbifera. J Tradit Chin Med. 2:37–38.
   Google Scholar
• Jin AP. 1996. A case of abnormal liver function associated with Dioscorea bulbifera use. China J Chin Mater Med. 2(6):57.
   Google Scholar
• Kawasaki T, Komori T, Setoguchi S. 1968. Furanoid Norditerpenes from Dioscoreaceae Plants. I. Diosbulbins A, B and C from Dioscorea bulbifera L. forma spontanea MAKINO et NEMOTO. Chem Pharm Bull. 16(12):2430–2435.
   Web of Science ®Google Scholar
• Komori T. 1997. Glycosides from Dioscorea bulbifera. Toxicon. 35(10):1531–1535.
   PubMed Web of Science ®Google Scholar
• Kong XL, Li H, Zhu JX, Wang Y. 2004. A case of suspected drug-induced liver disease induced by Chinese patent medicine Baishi Pills. Jiangsu Pharm Clin Res. 12(S1):79.
   Google Scholar
• Li JX, Yu HS, Song YT, Jia QH. 2013. Advances in modern research on Dioscorea bulbifera. Guide China Med. 11(26):52–55.
   Google Scholar
• Li Q. 2006. Icterohepatitis associated with Zhaoyulongyikong pills. Adv Drug Reactions J. 8(3):216.
   Google Scholar
• Li SS, Deng JZ, Zhao SX. 1999. Steroids from tuber of Dioscorea bulbifera L. J Plant Res Environ. 8(2):61–62.
   Google Scholar
• Li W, Lin D, Gao H, Xu Y, Meng D, Smith CV, Ying P, Zheng J. 2016. Metabolic activation of furan moiety makes Diosbulbin B hepatotoxic. Arch Toxicol. 90(4):863–872.
   PubMed Web of Science ®Google Scholar
• Li WC, Yang J, Li HW, Wang BY. 2009. A case of drug-induced liver disease caused by Dioscorea bulbifera. Chin J Clin Rational Drug Use. 2(15):79.
   Google Scholar
• Liao ZQ. 1980. 11 case reports of toxic hepatitis induced by Dioscorea bulbifera. Zhejiang Med J. 3:30–31.
   Google Scholar
• Liao ZQ, Chen AY. 1994. 16 case reports of toxic hepatitis induced by Dioscorea bulbifera. Chin J Integr Tradit West Med on Liver. 4(1):55.
   Google Scholar
• Lin D, Guo X, Gao H, Cheng L, Cheng M, Song S, Peng Y, Zheng J. 2015. In vitro and in vivo studies of the metabolic activation of 8-epidiosbulbin E acetate. Chem Res Toxicol. 28(9):1737–1746.
   PubMed Web of Science ®Google Scholar
• Lin D, Li C, Peng Y, Gao H, Zheng J. 2014. Cytochrome P450-mediated metabolic activation of diosbulbin B. Drug Metab Dispos. 42(10):1727–1736.
   PubMed Web of Science ®Google Scholar
• Lin D, Li W, Peng Y, Jiang C, Xu Y, Gao H, Zheng J. 2016. Role of metabolic activation in 8-epidiosbulbin E acetate-induced liver injury: mechanism of action of the hepatotoxic furanoid. Chem Res Toxicol. 29(3):359–366.
   PubMed Web of Science ®Google Scholar
• Lin D, Li W, Tian X, Peng Y, Zheng J. 2019. In vitro DNA adduction resulting from metabolic activation of diosbulbin B and 8-epidiosbulbin E acetate. Chem Res Toxicol. 32(1):38–48.
   PubMed Web of Science ®Google Scholar
• Lin D, Wang K, Guo X, Gao H, Peng Y, Zheng J. 2016. Lysine- and cysteine-based protein adductions derived from toxic metabolites of 8-epidiosbulbin E acetate. Toxicol Lett. 264:20–28.
   PubMed Web of Science ®Google Scholar
• Lin HW, Zhang G, Zhao HB, Zhang C, Lin GL. 2002. Advances in studies on Dioscorea bulbifera. Chin Tradit Herb Drugs. 33(2):175–177.
   Google Scholar
• Liu H, Chou GX, Guo YL, Ji LL, Wang JM, Wang ZT. 2010. Norclerodane diterpenoids from rhizomes of Dioscorea bulbifera. Phytochemistry. 71(10):1174–1180.
   PubMed Web of Science ®Google Scholar
• Liu H, Chou GX, Wang JM, Ji LL, Wang ZT. 2011. Steroidal saponins from the rhizomes of Dioscorea bulbifera and their cytotoxic activity. Planta Med. 77(8):845–848.
   PubMed Web of Science ®Google Scholar
• Liu H, Chou GX, Wu T, Guo YL, Wang SC, Wang CH, Wang ZT. 2009. Steroidal sapogenins and glycosides from the rhizomes of Dioscorea bulbifera. J Nat Prod. 72(11):1964–1968.
   PubMed Web of Science ®Google Scholar
• Liu SL, Xiong NN, Zou JD, Jiang M, Ning KQ, Wang H. 2005. Clinical report on hepatic function lesion caused by Rongbishu capsule for treating benign prostatic hyperplasia. Chin J Evid-Based Med. 05(3):229–231.
   Google Scholar
• Liu TT. 1982. 1 case report of hepatic damage induced by Dioscorea bulbifera. J Tradit Chin Med. 23(04):32.
   Google Scholar
• Liu X, Liu YO, Liang Y. 2013. A case of drug-induced liver injury caused by simvastatin and Longbishu capsules. Pharmacy Administration Commision of Chinese Hospital Association. Proceedings of the 2013 China Clinical Pharmacy Academic Annual Meeting and the 9th Clinical Pharmacists Forum; Jun 14–15; Nanchang (China): Pharmacy Administration Commision of Chinese Hospital Association.
   Google Scholar
• Liu XD, Wen W. 1999. A case of severe liver damage associated with Dioscorea bulbifera use. Chin J Integr Tradit West Med on Liver. 9(2):20.
   Google Scholar
• Lu XH, Wu QH. 2014. Literature analysis of 33 cases of liver injury induced by the compound preparation of Dioscorea bulbifera L. Sichuan J Tradit Chin Med. 32(9):162–164.
   Google Scholar
• Ma M, Jiang Z, Ruan J, Tan X, Liu J, Wang C, Zha XM, Zhang L. 2012. The furano norclerodane diterpenoid disobulbin-D induces apoptosis in normal human liver L-02 cells. Exp Toxicol Pathol. 64(6):611–618.
   PubMedGoogle Scholar
• Ma Y, Niu C, Wang J, Ji L, Wang Z. 2014. Diosbulbin B-induced liver injury in mice and its mechanism. Hum Exp Toxicol. 33(7):729–736.
   PubMed Web of Science ®Google Scholar
• Murray RDH, Jorge ZD, Khan NH, Shahjahan M, Quaisuddin M. 1984. Diosbulbin D and 8-epidiosbulbin E acetate, norclerodane diterpenoids from Dioscorea bulbifera tubers. Phytochemistry. 23(3):623–625.
   Web of Science ®Google Scholar
• Niu C, Wang J, Ji L, Wang Z. 2014. Protection of Angelica sinensis (Oliv) diels against hepatotoxicity induced by Dioscorea bulbifera L. and its mechanism. Biosci Trends. 8(5):253–259.
   PubMed Web of Science ®Google Scholar
• Okigbo RN, Anuagasi CL, Amadi JE, Ukpabi UJ. 2009. Potential inhibitory effects of some African tuberous plant extracts on Escherichia coli, Staphylococcus aureus and Candida albicans. Int J Integr Biol. 6(2):91–98.
   Google Scholar
• Ravindranath V, Burka LT, Boyd MR. 1984. Reactive metabolites from the bioactivation of toxic methylfurans. Science. 224(4651):884–886.
   PubMed Web of Science ®Google Scholar
• Shen XR, Dong JY. 2015. Determination of diosbulbin B in Dioscorea bulbifera L. from different regions. Herald Med. 34(7):394–397.
   Google Scholar
• Shi HY, Wang ZX. 2005. 2 cases of liver damage induced by Dioscorea bulbifera. Zhejiang Integr Tradit Chin West Med. 15(3):63–64.
   Google Scholar
• Shriram V, Jahagirdar S, Latha C, Kumar V, Puranik V, Rojatkar S, Dhakephalkar PK, Shitole MG. 2008. A potential plasmid-curing agent, 8-epidiosbulbin E acetate, from Dioscorea bulbifera L. against multidrug-resistant bacteria. Int J Antimicrob Agents. 32(5):405–410.
   PubMed Web of Science ®Google Scholar
• Song FL, Gan RY, Zhang Y, Xiao Q, Kuang L, Li HB. 2010. Total phenolic contents and antioxidant capacities of selected Chinese medicinal plants. Int J Mol Sci. 11(6):2362–2372.
   PubMed Web of Science ®Google Scholar
• Su L, Zhu JH, Cheng LB. 2003. Experimental pathological study of subacute intoxication by Dioscorea bulbifera L. J Forensic Med. 19(2):81–83.
   Google Scholar
• Subasini U, Thenmozhi S, Sathyamurthy D, Vetriselvan S, Rajamanickam GV, Dubey GP. 2013. Pharmacognostic and phytochemical investigations of Dioscorea bulbifera L. Int J Pharm Life Sci. 4(5):2693–2700.
   Google Scholar
• Tan XQ, Ruan JL, Chen HS, Wang JY. 2003. Studies on liver-toxicity in Rhigoma of Dioscorea bulbifera. China J Chin Mater Med. 28(7):661–663.
   Google Scholar
• Tang Y, Xue YB, Zhou L, Zhang JW, Yao GM, Luo ZW, Du G, Zhang YH. 2014. New norclerodane diterpenoids from the tubers of Dioscorea bulbifera. Chem Pharm Bull. 62(7):719–724.
   PubMed Web of Science ®Google Scholar
• Wang G, Liu JS, Lin BB, Wang GK, Liu JK. 2009. Two new furanoid norditerpenes from Dioscorea bulbifera. Chem Pharm Bull. 57(6):625–627.
   PubMed Web of Science ®Google Scholar
• Wang J, Liang Q, Ji L, Liu H, Wang C, Wang Z. 2011. Gender-related difference in liver injury induced by Dioscorea bulbifera L. rhizome in mice. Hum Exp Toxicol. 30(9):1333–1341.
   PubMed Web of Science ®Google Scholar
• Wang JM, Ji LL, Liu H, Wang ZT. 2010. Study of the hepatotoxicity induced by Dioscorea bulbifera L. rhizome in mice. Biosci Trends. 4(2):79–85.
   PubMed Web of Science ®Google Scholar
• Wang JZ, Liu SM, Zhao Y, Tang Q. 2009. The effects of different treatments of Dioscorea bulbifera alcohol extract on hepatotoxicity. Inf Tradit Chin Med. 26(2):21–22.
   Google Scholar
• Wang K, Li W, Chen J, Peng Y, Zheng J. 2015. Detection of cysteine- and lysine-based protein adductions by reactive metabolites of 2,5-dimethylfuran. Anal Chim Acta. 896:93–101.
   PubMed Web of Science ®Google Scholar
• Wang K, Lin D, Guo X, Huang W, Zheng J, Peng Y. 2017. Chemical identity of interaction of protein with reactive metabolite of diosbulbin B in vitro and in vivo. Toxins. 9(8):249.
   PubMed Web of Science ®Google Scholar
• Wang K, Zheng L, Peng Y, Song J, Zheng J. 2014. Selective and sensitive platform for function-based screening of potentially harmful furans. Anal Chem. 6(21):10755–10762.
   Web of Science ®Google Scholar
• Wang LL, Zhao DS, Shi W, Li ZQ, Wu ZT, Li P, Li HJ. 2017. Describing the holistic toxicokinetics of hepatotoxic Chinese herbal medicines by a novel integrated strategy: Dioscorea bulbifera rhizome as a case study. J Chromatogr B Analyt Technol Biomed Life Sci. 1064:40–48.
   PubMed Web of Science ®Google Scholar
• Wu XX, Zhong H, Zang KT. 2000. A case of liver damage induced by Dioscorea bulbifera. Lishizhen Med Mater Med Res. 11(2):186.
   Google Scholar
• Wu ZM, Liao F, Jia GQ. 2012. A case of acute liver failure induced by Bashi Pills. Chin J Dermatol. 45(12):858.
   Google Scholar
• Xu Y, Chen CC, Yang L, Wang JM, Ji LL, Wang ZT, Hu ZB. 2011. Evaluation on hepatotoxicity caused by Dioscorea bulbifera based on analysis of bile acids. Acta Pharm Sin. 46(1):39–44.
   Google Scholar
• Xu YZ, Bai CX, Zhou Q, Shen XW, Zheng SZ, Fu ZS, Chen H. 1988. Study on the ethanol extract of Dioscorea bulbifera in inhibiting inactivated-virus. Chin Pharm J. 23(09):535–537.
   Google Scholar
• Xu ZL, Ding ZZ. 1999. Study of Dioscorea bulbifera L. Chinese Herb Med. 24(8):496–498.
   Google Scholar
• Yang B, Liu W, Chen K, Wang Z, Wang C. 2014. Metabolism of diosbulbin B in vitro and in vivo in rats: formation of reactive metabolites and human enzymes involved. Drug Metab Dispos. 42(10):1737–1750.
   PubMed Web of Science ®Google Scholar
• Yang F, Liang Y, Xu L, Ji L, Yao N, Liu R, Shi L, Liang T. 2016. Exploration in the cascade working mechanisms of liver injury induced by total saponins extracted from Rhizoma Dioscorea bulbifera. Biomed Pharmacother. 83:1048–1056.
   PubMed Web of Science ®Google Scholar
• Ye J, Xue M, Liu Y, Zhu S, Li Y, Liu X, Cai D, Rui J, Zhang L. 2019. Diosbulbin B-induced mitochondria-dependent apoptosis in L-02 hepatocytes is regulated by ROS-mediated autophagy. Front Pharmacol. 10:676.
   PubMed Web of Science ®Google Scholar
• Yonemitsu M, Fukuda N, Kimura T, Komori T. 1993. Diosbulbin-B from the leaves and stems of Dioscorea bulbifera: 1H-1H and 13C-1H COSY NMR studies. Planta Med. 59(6):577.
   PubMed Web of Science ®Google Scholar
• Zhang HM, Yuan JY. 2009. The progress of diosbulbin B research on pharmacology and toxicology. Herald Med. 28:490–492.
   Google Scholar
• Zhang JZ. 2007. Zengshengping tablets-induced hepatic damage. Adv Drug Reactions J. 9(3):215.
   Google Scholar
• Zhang LP, Zhou HP. 2009. A case of death caused by Dioscorea bulbifera. Herald Med. 28(8):1097.
   Google Scholar
• Zhang QL, Jia Y, Yixia L. 2010. Liver damage due to Baishi Pills. Adv Drug Reactions J. 12(4):297–298.
   Google Scholar
• Zhang Y, Miao H, Guan H, Wang C, Wang Z, Ji L. 2019. Long-term diosbulbin B treatment induced liver fibrosis in mice. Chem Biol Interact. 298:15–23.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lin D, Li W, Gao H, Peng Y, Zheng J. 2017. Sensitive bromine-based screening of potential toxic furanoids in Dioscorea bulbifera L. J Chromatogr B Analyt Technol Biomed Life Sci. 1057:1–14.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tang W. 2018. Drug metabolism in drug discovery and development. Acta Pharm Sin B. 8(5):721–732.
   PubMed Web of Science ®Google Scholar
• Zhao DS, Jiang LL, Wang LL, Wu ZT, Li ZQ, Shi W, Li P, Jiang Y, Li HJ. 2018. Integrated metabolomics and proteomics approach to identify metabolic abnormalities in rats with Dioscorea bulbifera rhizome-induced hepatotoxicity. Chem Res Toxicol. 31(9):843–851.
   PubMed Web of Science ®Google Scholar
• Zhao DS, Wu ZT, Li ZQ, Wang LL, Jiang LL, Shi W, Li P, Jiang Y, Li HJ. 2018. Liver-specific metabolomics characterizes the hepatotoxicity of Dioscorea bulbifera rhizome in rats by integration of GC-MS and 1H-NMR. J Ethnopharmacol. 226:111–119.
   PubMed Web of Science ®Google Scholar
• Zhao WY. 2004. 2 cases of drug-induced liver disease induced by Baishi Pills. J Qiqihar Med Coll. 25(7):766.
   Google Scholar
• Zhao XJ, Yan XS, Sun DD. 2012. Pharmacological research and clinical progress of Rhizoma Dioscorea bulbiferae. Drug Eval Res. 35(2):147–149.
   Google Scholar
• Zhou HM, Wang JC. 1989. 3 case reports of toxic hepatitis caused by Dioscorea bulbifera in the treatment of Hashimoto’s thyroiditis. Shandong J Tradit Chin Med. 8(2):29.
   Google Scholar
• Zhou KM, Shi LL, Yin YY. 2006. A case of acute jaundice type drug-induced hepatitis induced by Baishi Pills. J Clin Dermatol. 35(11):737–738.
   Google Scholar